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ELECTROPHYSIOLOGY ARRHYTHMIAS - CLINICAL-
VENTRICULAR
Effects of Intraventricular Conduction Delay on
Survival in Patients Taking Antiarrhythmic Drugs
Localization of the Return Pathway in Ischemic
Ventricular Tachycardia by Diastolic Potential
Mapping
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Junichi Saito, Eugene Downar, J. Colin Doig, Louise Harris, Linda Mickleborough,
Stephane Masse, Elias Sevaptsidis, Mei-Hao Shi, Shane Kimber, Thomas
C.K. Chen. Toronto General Hospital, Toronto, Canada
Successful treatment of ischemic VT, including by catheter ablation, requires
accurate interpretation of the local electrograms. Diastolic potentials may be
recorded over a wide area of the endocardium. This study investigated the
relationship of the return pathway in VT to the area displaying diastolic ac-
tivity. 78 VTs in 30 patients were mapped endocardially at time of surgery.
Complete return pathways were seen in 17 VTs of 10 patients. The return
pathway was defined by tracking diastolic potentials from the earliest dias-
tolic signal towards the site of VT origin. Conduction time over the return
pathway represented the diastolic interval. The area of diastolic activity was
determined by calculating the area enclosed by electrodes showing diastolic
potentials from an inflated endocardial balloon.
Result: The mean return pathway conduction time was 90 ± 31 ms (range
40--140 ms). Mean diastolic interval was 64 ± 23 ms Irange 30-115 ms). The
mean area over which diastolic activity could be seen was 317 ± 255 mm2
(range 28-920 mm2). In all 17 VTs, diastolic activity was seen within 15 mm
of site of origin, and this represented an area of 98 ± 65 mm2 (range 28-170
mm2). 62% local electrograms within 15 mm of site of origin showed a dias-
tolic potential to GRS interval < 70 ms. All patients with such a pattern were
cured by surgery, but 2 of 4 patients with diastolic potential to GRS interval
~70 ms had VT recurrence. VT cycle length correlated with the conduction
time of return pathway (R ~ 0.765, p = 0.0002), but not with the area of the
retu rn pathway.
Implication: 1) Region exhibiting diastolic potentials was far greater than
the return pathway per se. 2) Characterization of the timing of diastolic po-
tentials relative to the GRS complex helps to identify critical portions of the
return pathway close to the VT site of origin. 3) Such analysis may differen-
tiate critical areas of the return pathway from bystander regions. 4) These
observations may help direct radio-frequency ablation in the catheter labora-
tory.
37 Irange 6-64) years (yrs), and mean follow-up of 24 (range 1-51) months,
including 30 pts with >2 yrs follow-up. Symptoms prior to ablation were
presyncope (27 pts), palpitations (21 pts), syncope (8 pts), and chest pain (1
pt). The mean duration of symptomatic VT prior to ablation was 4.2 yrs (range
6wks.-25 yrs.). A mean of 2.3 (range 1-6) drug trials failed to suppress VT. VT
mapped to the right ventricular outflow tract (RVOT) in 36 of the 58 pts. Four-
teen of 22 non-RVOT VTs mapped to the left ventricle (LV) and 8 mapped
to the right ventricle (RV) 16 RV inflow; 2 RV free wall). Eight of 14 LV VTs
were left posterior fascicular. RFCA targeting non-fascicular VTs was guided
by the earliest endocardial activation time and pace mapping. Fascicular VT
was guided by early Purkinje potentials. Overall, RFCA eliminated VT in 49 of
57 (86%) pts. In patients with RVOT VT, RFCA eliminated VT in 35/35 (100%)
pts. Non-RVOT VT was successfully ablated in 14/22 (63%) pts, including 7/8
(88%) with left posterior fascicular VT. Two pts required 2 RFCA sessions for
success (1 RVOT and 1 non-RVOT). Two pts were treated for post-procedure
pericardia I effusions and one developed a transient segmental wall motion
abnormality. During follow-up, no patient had spontaneous or inducible VT
or died. Conclusion: 1.) RFCA for idiopathic VT is feasible and safe in a large
patient cohort. 2.) The success rate is higher for RVOT VT. 3.) Neither late
recurrence nor proarrythmia has been observed.
Leon Greene, Robert Peters, Ruth McBride, John McAnulty, CAST Investigators.
Oregon Health Sciences UniversitY- Portland. Oregon
An intraventricular conduction delay (IVCD) may influence the efficacy and
safety of antiarrhythmic (AA) drugs. The Cardiac Arrhythmia Suppression
Trial (CAST) allows assessment of the influence of an IVCD on survival when
AA drugs are used following a myocardial infarction IMI). In CAST, MI pa-
tients with frequent ventricular premature depolarization (VPDs) laveraging
28 VPD/H) were randomized to receive an AA drug (flecainide, encainide or
moricizine) or a placebo. After therapy was started 956 patients (35%) had
an IVCD (GRS :': 0.11 sec) and 1796 patients (65%) had a GRS < 0.11 sec.
Patients IVCD patients differed from those with normal conduction by: be-
ing older (72% > age 60 vs. 54%); more often having an ejection fraction
<0.30 130% vs. 21 %); more often having >50 VPD/H at baseline (51 % vs.
43%): and having more pre-CAST Mis (45% vs. 38%) (P < 0.001 for each).
Mean follow-up was 1.1 years.
Results
1901-611
1901-621
Radiofrequency Catheter Ablation of Idiopathic
Ventricular Tachycardia in 57 Patients: Acute
Success and Long Term Follow-up
Slow Fragmented Intraatrial Conduction Post
Maze Procedure: A Substrate for Intraatrial
Reentrant Tachycardia and Marker for Effective
Radiofrequency Ablation
Right Coronary Artery Obstruction After
Radiofrequency Current Application at Right
Atrial Myocardium in Young Pigs
Thomas Paul, Regina B6kenkamp, Magdalena Zimmermann, Britta Mahnert, Hans
J. Trappe, Anne Maal?>, Rudolf SOmpelmann, Thomas Grater, Hans C. Kallfelz.
Hannover Medical School, Hannover; FR, Germany
Conclusions: Slow intraatrial tachycardias may be observed in symp-
tomatic post-maze patients. Our findings are consistent with slow conduc-
tion and reentry along a line of conduction block. Radiofrequency catheter
ablation can be curative for these tachycardias.
John M. Mandroia, Lawrence S. Klein, William M. Miles, David P Rardon, Raul
D. Mitrani, Douglas P. Zipes. Krannert Inst of Cardiol, Indiana Univ Sch of Med, VAMC,
Indianapolis, Indiana
Several centers have reported successful radiofrequency catheter ablation
(RFCA) of ventricular tachycardia (VT) in patients (pts) without structural
heart disease (idiopathic VT). Long term follow-up, however, has not been
reported. We performed RFCA in 57 pts (23 females) with a mean age of
Anatomical sequelae after creation of right atrial myocardial lesions by ra-
diofrequency current (RFC) application have not been studied in detail in
young subjects. During general anesthesia, a steerable 6 French electrode
catheter, equipped with a thermistor at the 4 mm tip electrode, was posi-
tioned at the lateral atrial aspect of the tricuspid valve anulus in 10 piglets
(german landrace, age 6 weeks, mean body weight 12.5 kg). RFC (500 kHz)
was delivered temperature-guided (75 'C) over 30 sec. Right atrial RFC le-
sions were studied macroscopically and microscopically in 5 animals after
48 hours, the remaining 5 animals were examined after 6 months.
After 48 hours, RFC lesions presented as transmural grey-white coagula-
tion necrosis. Lesions were sharply demarcated by a lymphocytic wall. Lym-
phocytic infiltration around the lesions extended to the right coronary artery
in 4/5 animals and to right ventricular myocardium in 3/5 piglets.
After 6 months, lesions consisted of transmural white scar tissue extend-
ing to the right ventricular myocardium in 2/5 animals. Layers of the right
coronary artery were affected in 4/5 pigs. In 2 animals, the lumen of the right
coronary artery was obstructed due to intimal thickening by 25 and 40%,
respectively.
Conclusion: Results should be taken into account when radiofrequency
current application at the atrial aspect of the tricuspid valve anulus is consid-
ered in infants and small children.
James M. Kleman, Richard Sterba, Gregory A. Kidwell. The Cleveland ClInic
Foundation, Cleveland, OH
The maze procedure is a surgical alternative for treating drug refractory atrial
fibrillation. Although post-maze atrial fibrillation has been noted, slow intraa-
trial tachycardias have not been reported. Of 31 maze patients with a mean
follow-up of 22 ± 9 months, 6 underwent electro physiologic (EP) testing (9
± 6 months post-op) for symptoms suggestive of recurrent arrhythmia. Re-
sults: Conduction was significantly prolonged through the right compared
to the left atrium (167 ± 44 vs 57 ± 10 ms, p < 0.01). However, right atrial
effective refractory periods were normal (237 ± 29 msl. Programmed atrial
stimulation induced sustained slow intraatrial reentry in two patients (cycle
lengths of 420 and 520 ms) and atrial flutter (cycle length 190 ms) in one
patient. The slow reentrant tachycardias were successfully ablated with ra-
diofrequency energy in both patients. Neither patient has experienced a clin-
ical recurrence after 14 and 9 months. Electrograms at successful ablation
sites were markedly fragmented during sinus rhythm, with an apparent re-
versal of near/far-field activation during tachycardia (see figure).
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After adjusting for age, ejection fraction and prior MI, the combination of
IVCD and antiarrhythmic drug remains a significant predictor of increased
mortality (hazard ratio 1.69, P ~ 0.04).
Conclusion Antiarrhythmic drug use is associated with and possibly a
cause of increased mortality and arrhythmic deaths in patients with an IVCD.
ELECTROPHYSIOLOGY - BASIC
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simultaneously. Following imaging, the slices were fixed in formaldehyde
then stored at 4'C in 30% sucrose/phosphate buffer until processing for im-
munohistochemistry.
All of the hearts showed homogeneous thallium perfusion, however there
was evidence of a regional decrease in MIBG uptake ranging from 10% to
45% of the left ventricle, consistent with regional denervation. The defects
were generally localized to the anterior and septal territories. Immunocy-
tochemial studies on sections from regions with decreased MIBG uptake
showed a striking paucity of nerves compared to regions with normal MIBG
uptake, confirming denelVation. While all of the hearts showed denelVation,
2/3 with severe arrhythmia showed either extensive denervation or a steep
gradient in MIBG uptake, while 1/4 of the mildly affected or dogs without
arrhythmias showed extensive denervation.
We conclude that there is abnormal heterogeneous sympathetic innerva-
tion in this population of dogs with spontaneous naturally occurring ven-
tricular arrhythmias and increased incidence of sudden cardiac death. This
heterogeneity of innervation may playa role in the etiology of ventricular
arrhythmia, particularly during states of increased sympathetic tone,
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Conclusion. The negative dromotropic effect of VS, VS during SS and ISO
is attenuated by L-NMMA and restored toward baseline by L-arginine, sug-
gesting that NO plays a partial role at both prejunctional and postjunctional
sites in the vagal modulation of AV nodal conduction.
Arif Elvan, Harald P. Pride, Douglas P. Zipes. lVannertlnstitute of Cardiology,
Indianapolis, IN
Introduction. Nitric oxide (NO), synthesized from L-arginine, is involved in the
modulation of autonomic neurotransmission. Recent in vitro and in vivo stud-
ies have shown that the negative chronotropic effect of carbachol or vagal
stimulation was partially blocked by an L-arginine analog, NG-monomethyl-
L-arginine (L-NMMA), that competetively inhibits NO synthase (NOS). The
purpose of the present study was to assess in an open chest canine model
whether the L-arginine-NO pathway may also playa role in the autonomic
modulation of AV nodal conduction, and if so, whether this is prejunctional
or postjunctional.
Methods and Results. To test for prejunctional actions, we assessed the
dromotropic response to cervical vagal stimulation (VS: 2 Hz, 4.0 V. 4 ms)
and VS during ansae subclaviae stimulation (SS: 2 Hz, 3.0 V. 4 ms, n = 5).
To test for postjunctional actions, we determined the dromotropic response
to intravenous isoproterenol infusion (5 mcg/min) before and during vagal
stimulation (VS + ISO, n = 5). VS, SS and ISO were repeated during selec-
tive infusion of L-NMMA retrogradely into the AV node artery (AVNA) and
following reversal of NOS inhibition with L-arginine (100 mg/kg). Shown is
the change in AV nodal conduction time (AH, msec) produced by VS before
and during SS or isoproterenol at control state (saline infusion into AVNA, 1
mllmin), during L-NMMA infusion (4 mg/min) into AVNA, and after IV injection
of L-arginine (100 mg/kg).
*p < 0.01 vs baseline, t p < 0.01 vs L-NMMA
Role of Nitric Oxide in the Autonomic Modulation
of Atrioventricular Nodal Conduction in Dogs
2/6
R-PIA/glibenclamide
6/7*
R-PIA/propranolol
Vitamin E for Coronary Heart Disease: What is at
Stake?
EPIDEMIOLOGY/PREVENTION
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Background: Torsade de pointes (TDP) is thought to result from early af-
terdepolarizations (EADs). Although it has been shown that adenosine can
suppress catecholamine-induced EADs in isolated guinea pig ventricular my-
ocytes, its effects on TDP in vivo are uncertain.
Methods: TDP was induced in 25 anesthetized rabbits weighing 3-4 kg
by simultaneous intravenous infusion of methoxamine, an ''1-adrenoceptor
agonist (70 nmol/kg/minl, and clofilium, a blocker of the delayed rectifier K+
channel (76 nmol/kg/minl. AfterTDP was initiated, saline (n = 6) orthe adeno-
sine Al receptor agonist R-phenylisopropyladenosine (R-PIA, 1.3 mg/kg, n =
61 was infused. Two additional groups were pretreated with propranolol (2
/-Lmol/kg, n = 7), a ,Il-adrenoceptor blocker, or glibenclamide (10 /-Lmol/kg, n
= 6). an ATP sensitive K+ channel (IK-ATP) blocker. prior to R-PIA infusion.
Results:
Suppression of TOP
Adenosine Al Receptor Activation Suppresses
Torsade De Pointes by Opening ATP Sensitive K+
Channels in Rabbits
Hanno L. Tan. Charles J,y' Hou, Eric Adler, Ruey J, Sung. Stanford University Medical
Center. Stanford, CA
Suppression of TDP in the R-PIA and the R-PIA/propranolol groups was not
associated with shortening of the OT interval (baseline: 205 ± 9 ms, onset of
TDP: 344 ± 10 ms, after suppression of TDP: 400 ± 40 ms [p < NS vs onset
of TDP). mean ± SD). but with reduction of OT interval dispersion (2.7 ±
0,5%,7,5 ± 1,1 %, and 4.2 ± 0,7% [p < 0.05 vs onset of TDP], respectively).
as measured from 6 limb leads.
Conclusion: Adenosine A, receptor activation suppresses TDP induced
by K+ channel blockade primarily by opening IK-ATP, rather than byantago-
nizing ,Il-adrenoceptor mediated mechanisms. This effect is associated with
reduced OT interval dispersion, but not with OT interval shortening.
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Heterogeneous Sympathetic Innervation in
German Shepherd Dogs with Inherited Ventricular
Arrhythmia and Sudden Death
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Michael Dae, Philip Ursell, Randall Lee, Carole Stilson, Michael Chin, N.
Sydney Moise. University of California atSan Francisco; College of Veterinary
Medicine, Cornell University, Ithaca, NY
An inbred colony of German Shepherd dogs with spontaneous ventricular ar-
rhythmias and sudden death has recently been identified. The median age of
onset of the arrhythmia (4.5 months), the tendency for sudden death to occur
during REM sleep, duringffollowing exercise, and the absence of structural
heart disease suggest a developmental abnormality of the autonomic inner-
vation to the heart. To further evaluate this possibility, we studied 7 dogs from
this colony, mean age 5.2 months. Three of seven were severely affected
(frequent VT on holter). two were mildly affected, and two had no arrhyth-
mias by holter analysis. We imaged the distribution of functional myocardial
sympathetic innervation and perfusion using 1-123 metaiodobenzylguanidine
(MIBG) and thallium-201 respectively. Sympathetic nerve distribution was
evaluated morphologically by immunocytochemical localization of tyrosine
hydroxylase. Six mCi of 1-123 M IBG was injected IV followed three hours later
by 2 mCi of thallium-201. The hearts were excised, sliced transversely, and
imaged directly for MIBG and thallium. Color functional maps were derived
to display the distribution of innervation (MIBG) and perfusion (thallium-2011
Kurt C. Fabrick, Murray A. Mittleman, Joel Tsevat, Paula A. Goldman, Larry
W. Williams, Lee Goldman, Milton C. Weinstein, Brigham and Women's Hospital,
Harvard Medical School and the Harvard School ofPublic Health. Boston, MA
Two recent epidemiologic studies reported that subjects taking vitamin E(vit
E) supplements had about a 40% reduction in major coronary heart disease
(CHD) events compared with those in the lowest quintile of Vit E intake. The
Coronary Heart Disease Policy Model (CHDPM). a comprehensive computer
simulation of the costs and consequences of CHD in the US, was used to
analyze the cost-effectiveness of vit E.
The CHDPM uses age- and gender-specific distributions of CHD risk fac-
tors and age-, gender-, and risk factor-specific probabilities of disease onset
to estimate CHD and non-CHD death and morbidity. The CHDPM simulation
estimated the incremental cost-effectiveness (C/E) and the potential years of
life saved for primary (1 ') and secondary (2') prevention over 5 and 10 years.
The cost of therapy with vit E (200 IU/day) was set at $56.07/year.
For 2' prevention assuming the full efficacy observed in epidemiologic
studies, vit E saves both years of life and costs because of CHD averted,
Even at 1I8th efficacy (Men RR = 0.97, Women RR = 0,95). the incremental
C/E was $9,400 per year of life saved (YOLS) for men and $2,200 for women.
